B7-33
<
>
B7-33
B7-33

B7-33



Product Description

Basic Info.

B7-33 is a novel, synthetic compound that was first discovered and developed by a team of researchers at the Monash University in Australia. The development of B7-33 was based on the discovery of the relaxin receptor 1 (RXFP1) and the recognition of its potential as a therapeutic target for a wide range of diseases and conditions.

The research team, led by Professor David Handelsman, first synthesized B7-33 in the early 2010s as part of their efforts to develop a functionally selective agonist for RXFP1. This compound was then tested in a series of in vitro and in vivo studies, which demonstrated its potential as a treatment for hypertension, kidney disease, and heart failure. The team's research on B7-33 was published in several scientific journals, including the Journal of Biological Chemistry and the Journal of Hypertension. 

These publications highlighted the compound's unique mechanism of action and its potential as a treatment option for patients.

 

Send a Message



Product Categories

Hot products

(D200)MAST-200(Drostanolone Enanathate)

(D200)MAST-200(Drostanolone Enanathate)

Basic Info. Drostanolone enanthate is an analytical reference standard categorized as an anabolic androgenic steroid prodrug of drostanolone. ...

(SW50)STANOZOLOL suspension, 50(winstrol)

(SW50)STANOZOLOL suspension, 50(winstrol)

Basic Info. STANOZOLOL suspension primarily serves a therapeutic role in managing hereditary angioedema caused by C1-inhibitor deficiency. It helps regulate the body's complement system, reducing the frequency and severity of angioedema attacks that affect areas like the skin, airway, or gastrointestinal tract. ...

(SW100)STANOZOLOL suspension, 100(winstrol)

(SW100)STANOZOLOL suspension, 100(winstrol)

Basic Info. STANOZOLOL suspension primarily serves a therapeutic role in managing hereditary angioedema caused by C1-inhibitor deficiency. It helps regulate the body's complement system, reducing the frequency and severity of angioedema attacks that affect areas like the skin, airway, or gastrointestinal tract. ...

(U200)BU 200, or EQUIPOISE200(boldenone undecyleate)

(U200)BU 200, or EQUIPOISE200(boldenone undecyleate)

Basic Info. Boldenone undecylenate, is an androgen and anabolic steroid (AAS) medication which is used in veterinary medicine, mainly in horses. It was formerly used in humans as well. It is given by injection into muscle. ...

(U300)BU-300, or EQUIPOISE300(BOLDENONE UNDECYLENATE, or EQUIPOISE)

(U300)BU-300, or EQUIPOISE300(BOLDENONE UNDECYLENATE, or EQUIPOISE)

Basic Info. Boldenone undecylenate, is an androgen and anabolic steroid (AAS) medication which is used in veterinary medicine, mainly in horses. It was formerly used in humans as well. It is given by injection into muscle. ...